Efficacy and adverse events of octreotide long-acting release in acromegaly: a real-world retrospective study

BACKGROUND: Octreotide long-acting release (LAR) is a common drug used for acromegaly that aims to normalize serum growth hormone (GH) and insulin-like growth factor-1 (IGF-1). However, only a few studies have evaluated its efficacy and safety in Chinese patients. This retrospective study aimed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhe, Duan, Lian, Gao, Daihui, Yao, Yong, Deng, Kan, Xing, Bing, Wang, Xinfeng, Tang, Yan, Zhu, Huijuan, Chen, Xiaoguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358514/
https://www.ncbi.nlm.nih.gov/pubmed/35957714
http://dx.doi.org/10.21037/atm-22-414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358514/
https://www.ncbi.nlm.nih.gov/pubmed/35957714
http://dx.doi.org/10.21037/atm-22-414

Ejemplares similares